Umstead John W. V — SEC Form 4 filings

SEC reporting owner CIK 1967910. 6 Form 4 filings on record with FilingPulse; latest filed 2024-09-18.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-20 to 2024-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
G1 Therapeutics, Inc. (GTHX)Chief Financial Officer63 legs · 15,225 sh · $60,1077

Form 4 filings — Umstead John W. V

FiledFormIssuerReported transactionsSource
2024-09-184G1 Therapeutics, Inc. (GTHX)Disposition to issuer (D): 168,387 · Code (U): 19,331 · Disposition to issuer (D): 74,500 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 100,000 (derivative)EDGAR
2024-07-084G1 Therapeutics, Inc. (GTHX)Sale (S): 527 @ $2.51EDGAR
2024-07-034G1 Therapeutics, Inc. (GTHX)Grant/award (A): 35,000 @ $0EDGAR
2024-05-154G1 Therapeutics, Inc. (GTHX)Sale (S): 8,151 @ $4.79EDGAR
2024-03-224G1 Therapeutics, Inc. (GTHX)Grant/award (A): 37,500 @ $0EDGAR
2024-03-204G1 Therapeutics, Inc. (GTHX)Sale (S): 6,547 @ $3.02EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1967910 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →